InvestorsHub Logo
Followers 21
Posts 1234
Boards Moderated 0
Alias Born 12/10/2010

Re: Colby1 post# 5235

Tuesday, 03/04/2014 11:26:28 PM

Tuesday, March 04, 2014 11:26:28 PM

Post# of 700017
This article just came out! http://gdpinsider.com/brain-cancer-drug-key-for-northwest-biotherapeutics-inc-nasdaqnwbo-7339.html#respond Most analysts including those from Oppenheimer & Co have been of the opinion that the phase 3 trials which are currently being pursued by Northwest Biotherapeutics, Inc (NASDAQ:NWBO) on the target drug DCVax-L are a make or break situation for the firm. Analyst Boris Peaker of Oppenheimer has been quoted to have said that, “If the drug holds up in Phase III, it will be a very big win for the company because there aren’t many good options now for patients, and DCVax is certainly better tolerated than any chemotherapy. And if it works in brain cancer, it should work in other solid tumors.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News